Novacyt (NCYT) Competitors

GBX 69.60
+2.50 (+3.73%)
(As of 05/10/2024 ET)

NCYT vs. IUG, IHC, CREO, EKF, VLG, SPEC, ETX, TRX, REDX, and AREC

Should you be buying Novacyt stock or one of its competitors? The main competitors of Novacyt include Intelligent Ultrasound Group (IUG), Inspiration Healthcare Group (IHC), Creo Medical Group (CREO), EKF Diagnostics (EKF), Venture Life Group (VLG), INSPECS Group (SPEC), e-therapeutics (ETX), Tissue Regenix Group (TRX), Redx Pharma (REDX), and Arecor Therapeutics (AREC). These companies are all part of the "medical" sector.

Novacyt vs.

Novacyt (LON:NCYT) and Intelligent Ultrasound Group (LON:IUG) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their valuation, dividends, earnings, risk, profitability, analyst recommendations, institutional ownership, community ranking and media sentiment.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Novacyt
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A
Intelligent Ultrasound Group
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A

In the previous week, Novacyt's average media sentiment score of 0.00 equaled Intelligent Ultrasound Group'saverage media sentiment score.

Company Overall Sentiment
Novacyt Neutral
Intelligent Ultrasound Group Neutral

Intelligent Ultrasound Group has higher revenue and earnings than Novacyt. Intelligent Ultrasound Group is trading at a lower price-to-earnings ratio than Novacyt, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Novacyt£7.87M6.25-£25.30M-£0.36-193.33
Intelligent Ultrasound Group£11.17M2.46-£2.58M-£0.01-840.00

Novacyt has a net margin of 0.00% compared to Intelligent Ultrasound Group's net margin of -23.11%. Novacyt's return on equity of -21.08% beat Intelligent Ultrasound Group's return on equity.

Company Net Margins Return on Equity Return on Assets
NovacytN/A -21.08% -5.88%
Intelligent Ultrasound Group -23.11%-23.58%-12.67%

0.1% of Novacyt shares are held by institutional investors. Comparatively, 76.9% of Intelligent Ultrasound Group shares are held by institutional investors. 3.2% of Novacyt shares are held by company insiders. Comparatively, 13.4% of Intelligent Ultrasound Group shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Novacyt has a beta of -1.8, meaning that its share price is 280% less volatile than the S&P 500. Comparatively, Intelligent Ultrasound Group has a beta of 0.12, meaning that its share price is 88% less volatile than the S&P 500.

Novacyt received 36 more outperform votes than Intelligent Ultrasound Group when rated by MarketBeat users.

CompanyUnderperformOutperform
NovacytOutperform Votes
36
58.06%
Underperform Votes
26
41.94%
Intelligent Ultrasound GroupN/AN/A

Summary

Novacyt and Intelligent Ultrasound Group tied by winning 6 of the 12 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding NCYT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

NCYT vs. The Competition

MetricNovacytMedical Devices IndustryMedical SectorLON Exchange
Market Cap£49.16M£2.15B£5.11B£1.77B
Dividend YieldN/A2.55%38.09%6.84%
P/E Ratio-193.33240.10111.251,937.48
Price / Sales6.25256.932,415.51433,692.65
Price / Cash0.5816.3048.6435.51
Price / Book0.463.575.332.75
Net Income-£25.30M£61.06M£106.52M£183.11M
7 Day Performance2.35%1.58%-0.89%1.39%
1 Month Performance38.46%-0.62%-1.39%3.23%
1 Year Performance60.81%37.89%4.65%10.82%

Novacyt Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
IUG
Intelligent Ultrasound Group
0 of 5 stars
GBX 8.75
+4.9%
N/A-34.1%£28.60M£10.26M-875.0065Gap Up
IHC
Inspiration Healthcare Group
0 of 5 stars
GBX 31
flat
N/A-63.8%£21.15M£41.08M-3,100.00210Positive News
CREO
Creo Medical Group
0 of 5 stars
GBX 36
flat
N/AN/A£130.13M£29.27M-327.27279
EKF
EKF Diagnostics
0 of 5 stars
GBX 28.80
+2.7%
N/A+15.4%£130.67M£52.61M2,880.00356Gap Up
VLG
Venture Life Group
0 of 5 stars
GBX 40.50
flat
N/A-2.8%£51.23M£48.57M-4,050.00153
SPEC
INSPECS Group
0 of 5 stars
GBX 56
flat
N/A-44.8%£56.94M£202M-2,800.001,673
ETX
e-therapeutics
0 of 5 stars
GBX 9.88
+7.6%
N/A-30.8%£57.70M£295,000.00-493.7534Gap Up
TRX
Tissue Regenix Group
0 of 5 stars
GBX 61.50
flat
N/A+6.0%£43.40M£29.49M-3,075.0082
REDX
Redx Pharma
0 of 5 stars
GBX 15
+31.6%
N/A-53.8%£58.35M£4.20M-150.00101
AREC
Arecor Therapeutics
0 of 5 stars
GBX 136.50
flat
N/A-46.5%£41.81M£3.38M-440.3251News Coverage

Related Companies and Tools

This page (LON:NCYT) was last updated on 5/12/2024 by MarketBeat.com Staff

From Our Partners